Hormone Therapy clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate Pre-Exposure Prophylaxis (PrEP) levels in transgender-identifying or gender non-binary individuals taking versus not taking gender affirming hormone therapy. Subjects who have previously taken F/TDF as PrEP…
at UCSD
Our lead scientists for Hormone Therapy research studies include Sheldon Morris, MD.
Last updated: